|
Volumn 11, Issue 4, 2001, Pages 300-305
|
Women's primary health care and the search for quality
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
PROSTAGLANDIN DERIVATIVE;
TAXANE DERIVATIVE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
AFRICA;
ALOPECIA;
ARTICLE;
BALLOON CATHETER;
CANCER CENTER;
CESAREAN SECTION;
CHEMOTHERAPY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG ADMINISTRATION;
FEMALE;
HEALTH CARE QUALITY;
HUMAN;
HYPOTHESIS;
LABOR INDUCTION;
MANAGED CARE ORGANIZATION;
MATERNAL MORTALITY;
MEDICAL RESEARCH;
NAUSEA;
OBSTETRIC CARE;
OVARY CARCINOMA;
PAIN;
PERCEPTION;
PRACTICE GUIDELINE;
PRIMARY MEDICAL CARE;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
RISK ASSESSMENT;
STATISTICS;
TECHNIQUE;
UNITED KINGDOM;
UTERINE CERVIX RIPENING;
UTERUS CONTRACTION;
VOMITING;
DELIVERY OF HEALTH CARE;
FEMALE;
HUMANS;
PRACTICE GUIDELINES;
PRIMARY HEALTH CARE;
QUALITY ASSURANCE, HEALTH CARE;
UNITED STATES;
WOMEN'S HEALTH;
|
EID: 0034903177
PISSN: 10493867
EISSN: None
Source Type: Journal
DOI: 10.1016/S1049-3867(01)00097-4 Document Type: Article |
Times cited : (1)
|
References (10)
|